Publications by authors named "Nathan Gyabi Buziba"
Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort.
Oncologist
November 2023
Background: Although non-Hodgkin lymphoma (NHL) is the 6th most common malignancy in Sub-Saharan Africa (SSA), little is known about its management and outcome. Herein, we examined treatment patterns and survival among NHL patients.
Methods: We obtained a random sample of adult patients diagnosed between 2011 and 2015 from 11 population-based cancer registries in 10 SSA countries.
Background: Although prostate cancer (PCa) is the most commonly diagnosed cancer in men of sub-Saharan Africa (SSA), little is known about its management and survival. The objective of the current study was to describe the presentation, patterns of diagnosis, treatment, and survival of patients with PCa in 10 countries of SSA.
Methods: In this observational registry study with data collection from 2010 to 2018, the authors drew a random sample of 738 patients with PCa who were registered in 11 population-based cancer registries.
There are limited population-based survival data for colorectal cancer (CRC) in sub-Saharan Africa. Here, 1707 persons diagnosed with CRC from 2005 to 2015 were randomly selected from 13 population-based cancer registries operating in 11 countries in sub-Saharan Africa. Vital status was ascertained from medical charts or through next of kin.
View Article and Find Full Text PDFArticle Synopsis
- Cervical cancer is a major health issue in sub-Saharan Africa, being the second most common cancer and a leading cause of cancer-related deaths among women.
- An analysis of 10 cancer registries from eight countries showed that cervical cancer incidence has generally increased over the years, with Blantyre in Malawi presenting the highest annual increase at 7.9%.
- The findings emphasize the urgent need for effective prevention efforts, such as HPV vaccination and widespread screening, along with ongoing monitoring through cancer registries.